These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD. Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872 [TBL] [Abstract][Full Text] [Related]
3. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils. Alvarez-Puebla MJ; Olaguibel Rivera JM; Almudevar E; Echegoyen AA; de Esteban Chocarro B; Cambra K J Investig Allergol Clin Immunol; 2015; 25(2):107-11. PubMed ID: 25997303 [TBL] [Abstract][Full Text] [Related]
4. Exhaled nitric oxide is associated with allergic inflammation in children. Choi BS; Kim KW; Lee YJ; Baek J; Park HB; Kim YH; Sohn MH; Kim KE J Korean Med Sci; 2011 Oct; 26(10):1265-9. PubMed ID: 22022176 [TBL] [Abstract][Full Text] [Related]
5. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD. Zhang J; Wang X; Chen Y; Yao W Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529 [TBL] [Abstract][Full Text] [Related]
6. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629 [TBL] [Abstract][Full Text] [Related]
7. [Concentration of nitric oxide exhaled air (eNO) in patients with COPD and bronchiectasis]. Ziora D; Kałuska K; Rauer R; Kozielski J Pneumonol Alergol Pol; 2003; 71(9-10):418-27. PubMed ID: 15052978 [TBL] [Abstract][Full Text] [Related]
8. The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma. Tsuburai T; Tsurikisawa N; Taniguchi M; Morita S; Ono E; Oshikata C; Ohtomo M; Maeda Y; Ikehara K; Akiyama K Allergol Int; 2007 Mar; 56(1):37-43. PubMed ID: 17259808 [TBL] [Abstract][Full Text] [Related]
9. Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide. Soter S; Barta I; Antus B Inflammation; 2013 Oct; 36(5):1178-85. PubMed ID: 23681903 [TBL] [Abstract][Full Text] [Related]
10. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469 [TBL] [Abstract][Full Text] [Related]
11. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD). Mostafavi-Pour-Manshadi SM; Naderi N; Mancino P; Li PZ; Tan W; Bourbeau J COPD; 2020 Aug; 17(4):355-365. PubMed ID: 32584165 [TBL] [Abstract][Full Text] [Related]
12. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma. Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159 [TBL] [Abstract][Full Text] [Related]
13. Prediction of airway inflammation in patients with asymptomatic asthma by using lung sound analysis. Shimoda T; Nagasaka Y; Obase Y; Kishikawa R; Iwanaga T J Allergy Clin Immunol Pract; 2014; 2(6):727-32. PubMed ID: 25439364 [TBL] [Abstract][Full Text] [Related]
14. Airway inflammation and mannitol challenge test in COPD. de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520 [TBL] [Abstract][Full Text] [Related]
15. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap]. Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121 [TBL] [Abstract][Full Text] [Related]
16. Effects of exacerbations and seasonality on exhaled nitric oxide in COPD. Bhowmik A; Seemungal TA; Donaldson GC; Wedzicha JA Eur Respir J; 2005 Dec; 26(6):1009-15. PubMed ID: 16319329 [TBL] [Abstract][Full Text] [Related]
17. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease. Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888 [TBL] [Abstract][Full Text] [Related]
18. Post-bronchodilator Reversibility of FEV Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346 [TBL] [Abstract][Full Text] [Related]
19. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD. Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068 [TBL] [Abstract][Full Text] [Related]
20. Additive effect of eosinophilia and atopy on exhaled nitric oxide levels in children with or without a history of respiratory symptoms. Barreto M; Villa MP; Monti F; Bohmerova Z; Martella S; Montesano M; Darder MT; Ronchetti R Pediatr Allergy Immunol; 2005 Feb; 16(1):52-8. PubMed ID: 15693912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]